Clinical trial
Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
NCT00367991 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction
- Lead sponsor
- Yale University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- March 31, 2008
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.